Get the Daily Brief
Latest Biotech News
Cancer Biomarker and Imaging Research Accelerates with AI
Researchers have unveiled new AI-driven computational tools transforming biomarker discovery and medical imaging analysis. The recently published moPepGen platform enhances detection of diverse...
Advances in Sustainable and Circular Bioeconomy Strategies
A policy report highlights pathways for sustainable and circular aquaculture development in Germany and Brazil, emphasizing the potent yet underutilized freshwater aquaculture sectors. Separately,...
Neonatal Care Innovations: Training and Automated Monitoring
New educational programs using simulation-based training improve neonatal endotracheal intubation skills among clinicians, enhancing patient safety in critical care units. Complementing this,...
Lilly's $1.3 Billion Verve Therapeutics Acquisition Shakes Cardiovascular Gene Editing
Eli Lilly agreed to acquire Verve Therapeutics for up to $1.3 billion, marking a strategic move to expand its cardiovascular gene editing portfolio. Verve's lead program, VERVE-102, targets PCSK9...
Sarepta's Elevidys Gene Therapy Halted After Second Acute Liver Failure Death
Sarepta Therapeutics halted shipments of its DMD gene therapy Elevidys to non-ambulatory patients following a second fatal case of acute liver failure. Both deaths occurred in adolescent boys with...
Supernus Pharmaceuticals Acquires Sage Therapeutics for Up to $795 Million
Supernus Pharmaceuticals agreed to acquire Sage Therapeutics at an initial valuation of approximately $561 million, with additional contingent payments potentially increasing the deal value to...
FDA Introduces Accelerated Review Voucher Program Amid Workforce Strains
The U.S. Food and Drug Administration launched a new priority review voucher program intended to incentivize drug developers addressing national health priorities by offering accelerated review...
AI and Machine Learning Propel Breakthroughs in Drug Discovery and Diagnostics
Advances in artificial intelligence and machine learning are reshaping biotech, enabling novel protein design, diagnostic testing outside labs, and improved biomarker discovery. The AI-driven...
Emerging Dual Immunotherapy Extends Liver Cancer Patient Survival and Gains Global Approvals
Researchers at the University of Hong Kong pioneered a dual immunotherapy combining PD-1 inhibitor nivolumab and CTLA-4 blocker ipilimumab to treat advanced hepatocellular carcinoma. This...
Novel AI Application Boosts Public Health Campaigns Against HIV
Researchers led by Dolores Albarracin have deployed AI methods to classify and optimize public health messaging for HIV prevention targeting men who have sex with men (MSM). By analyzing a large...
Nanoneedle Patch Offers Painless, Repetitive Tissue Sampling for Disease Monitoring
Scientists at King’s College London developed a nanoneedle patch embedded with tens of millions of microscopic needles that collect molecular data from living tissues without causing pain or...
Single-Cell and Imaging Technologies Unlock Disease Mechanisms in Cancer and Autoimmunity
Cutting-edge single-cell RNA sequencing and multiplexed imaging advances deepen insights into complex diseases, including breast cancer heterogeneity and autoimmune disorders. Novel quantitative...
Significant Biopharma Deals Highlight Accelerating Investment in AI-Driven Drug Development
Biopharma deal-making remains brisk in 2025, with notable transactions including BioNTech's $1.25 billion acquisition of CureVac to advance mRNA oncology programs, Astrazeneca's $5.3 billion...
Sarepta Suspends Duchenne Gene Therapy After Second Liver Failure Death
Sarepta Therapeutics has temporarily halted shipments of its gene therapy Elevidys for non-ambulatory Duchenne muscular dystrophy (DMD) patients following a second death caused by acute liver...
Eli Lilly Expands Gene Editing Portfolio with Verve Acquisition
Eli Lilly announced the acquisition of gene-editing biotech Verve Therapeutics for up to $1.3 billion, acquiring full rights to Verve's PCSK9-targeting program aimed at one-time cardiovascular...
Breakthroughs in AI-Driven Protein Design and Drug Discovery
Innovative AI methodologies are transforming protein design and drug development. EMBL researchers introduced AlphaDesign, an AI framework advancing de novo protein creation with applications in...
Novel Cancer Therapeutics from Biotech and Academic Collaborations
Recent collaborations and discoveries are advancing cancer treatments. Mount Sinai’s OCCAM Immune and Cancer Research Institute joined forces to enhance immunotherapy outcomes through integrated...
Advanced Diagnostic Innovations Enhance Early Disease Detection
Emerging diagnostic technologies promise to revolutionize early disease detection and monitoring. King’s College London developed a nanoneedle patch enabling painless, repeated molecular profiling...
AI and Machine Learning Transform Biotech and Healthcare Workflows
Artificial intelligence continues reshaping biotech research and medical diagnostics. New frameworks for improved prompt training—such as Requirement-Oriented Prompt Engineering—help users...
Environmental and Microbial Studies Tackle Pollution and Ecosystem Dynamics
Cutting-edge research is addressing environmental challenges via microbial and ecological discoveries. Italian scientists identified bacteria in PFAS-contaminated Veneto soil capable of degrading...